Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,347 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Ichinose Y, Seto T, Sasaki T, Yamanaka T, Okamoto I, Takeda K, Tanaka M, Katakami N, Sawa T, Kudoh S, Saka H, Nishimura Y, Nakagawa K, Fukuoka M. Ichinose Y, et al. Among authors: tanaka m. J Thorac Oncol. 2011 Dec;6(12):2069-75. doi: 10.1097/JTO.0b013e3182307e5a. J Thorac Oncol. 2011. PMID: 22052226 Free article. Clinical Trial.
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002).
Nishimura Y, Nakagawa K, Takeda K, Tanaka M, Segawa Y, Tsujino K, Negoro S, Fuwa N, Hida T, Kawahara M, Katakami N, Hirokawa K, Yamamoto N, Fukuoka M, Ariyoshi Y. Nishimura Y, et al. Among authors: tanaka m. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):786-92. doi: 10.1016/j.ijrobp.2007.04.008. Epub 2007 May 23. Int J Radiat Oncol Biol Phys. 2007. PMID: 17512126 Clinical Trial.
A phase II study of cisplatin and irinotecan as induction chemotherapy followed by concomitant thoracic radiotherapy with weekly low-dose irinotecan in unresectable, stage III, non-small cell lung cancer: JCOG 9706.
Takeda K, Negoro S, Tanaka M, Fukuda H, Nakagawa K, Kawahara M, Semba H, Kudoh S, Sawa T, Saijo N, Fukuoka M. Takeda K, et al. Among authors: tanaka m. Jpn J Clin Oncol. 2011 Jan;41(1):25-31. doi: 10.1093/jjco/hyq163. Epub 2010 Aug 27. Jpn J Clin Oncol. 2011. PMID: 20802006 Clinical Trial.
Phase 2 Study of Nimotuzumab in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Non-Small-Cell Lung Cancer.
Yamamoto N, Harada H, Okamoto I, Masuda N, Hayakawa K, Satouchi M, Soejima T, Nishio M, Kozuka T, Takeda K, Tanaka M, Seto T, Sasaki T, Tsubouchi H, Kakurai Y, Nishimura Y, Nakagawa K. Yamamoto N, et al. Among authors: tanaka m. Clin Lung Cancer. 2021 Mar;22(2):134-141. doi: 10.1016/j.cllc.2020.12.012. Epub 2020 Dec 26. Clin Lung Cancer. 2021. PMID: 33518480 Free article. Clinical Trial.
A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer.
Harima Y, Ohguri T, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. Harima Y, et al. Among authors: tanaka m. Int J Hyperthermia. 2016 Nov;32(7):801-8. doi: 10.1080/02656736.2016.1213430. Epub 2016 Aug 12. Int J Hyperthermia. 2016. PMID: 27418208 Free article. Clinical Trial.
Relationships between thermal dose parameters and the efficacy of definitive chemoradiotherapy plus regional hyperthermia in the treatment of locally advanced cervical cancer: data from a multicentre randomised clinical trial.
Ohguri T, Harima Y, Imada H, Sakurai H, Ohno T, Hiraki Y, Tuji K, Tanaka M, Terashima H. Ohguri T, et al. Among authors: tanaka m. Int J Hyperthermia. 2018 Jun;34(4):461-468. doi: 10.1080/02656736.2017.1352105. Epub 2017 Jul 19. Int J Hyperthermia. 2018. PMID: 28679349 Free article. Clinical Trial.
15,347 results
You have reached the last available page of results. Please see the User Guide for more information.